Experts see it as the biggest breakthrough in pancreatic cancer treatment in decades: a daily pill that appears to shrink tumors in some patients with one of the deadliest and most difficult types of cancer, and may even destroy them.
This cancer was not diagnosed in the scans of one out of every 12 patients who received the drug Daroxonarasib in the initial medical tests along with chemotherapy.
Tumors stopped growing in almost all of the 61 participants newly diagnosed with advanced pancreatic cancer that had spread to other parts of the body.
But the doctors emphasize that there is still a long way to go before they know how long this drug can control the disease and it should not be considered a treatment.
Cancer Research UK called it "the biggest leap forward in decades" for pancreatic cancer patients. Pancreatic cancer is difficult to treat and has the lowest survival rate of all common cancers in the UK.
Getty Images 📸.